These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8823808)
21. Cyclocreatine in cancer chemotherapy. Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923 [TBL] [Abstract][Full Text] [Related]
22. Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine). Griffiths GR; Walker JB J Biol Chem; 1976 Apr; 251(7):2049-54. PubMed ID: 1270421 [TBL] [Abstract][Full Text] [Related]
23. [Current results and perspectives of the use of human tumor cell lines for antitumor drug screening]. Zhukova OS; Dobrynin IaV Vopr Onkol; 2001; 47(6):706-9. PubMed ID: 11826493 [TBL] [Abstract][Full Text] [Related]
24. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258 [TBL] [Abstract][Full Text] [Related]
25. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914 [TBL] [Abstract][Full Text] [Related]
26. Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase. Mulvaney PT; Stracke ML; Nam SW; Woodhouse E; O'Keefe M; Clair T; Liotta LA; Khaddurah-Daouk R; Schiffmann E Int J Cancer; 1998 Sep; 78(1):46-52. PubMed ID: 9724093 [TBL] [Abstract][Full Text] [Related]
27. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
28. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts. Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960 [TBL] [Abstract][Full Text] [Related]
29. Anticancer activities of novel chalcone and bis-chalcone derivatives. Modzelewska A; Pettit C; Achanta G; Davidson NE; Huang P; Khan SR Bioorg Med Chem; 2006 May; 14(10):3491-5. PubMed ID: 16434201 [TBL] [Abstract][Full Text] [Related]
30. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs. Osmak M; Kovacek I; Ljubenkov I; Spaventi R; Eckert-Maksić M Neoplasma; 1997; 44(2):101-7. PubMed ID: 9201289 [TBL] [Abstract][Full Text] [Related]
31. Anticancer versus antigrowth activities of three analogs of the growth-inhibitory peptide: relevance to physicochemical properties. Mizejewski GJ; Eisele L; Maccoll R Anticancer Res; 2006; 26(4B):3071-6. PubMed ID: 16886636 [TBL] [Abstract][Full Text] [Related]
32. The proteasome inhibitor PS-341 in cancer therapy. Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives. Teng CH; Won SJ; Lin CN Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756 [TBL] [Abstract][Full Text] [Related]
34. Protective effect of creatine against inhibition by methylglyoxal of mitochondrial respiration of cardiac cells. Roy SS; Biswas S; Ray M; Ray S Biochem J; 2003 Jun; 372(Pt 2):661-9. PubMed ID: 12605598 [TBL] [Abstract][Full Text] [Related]
35. Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models. Tejeda M; Gaal D; Hullán L; Csuka O; Schwab R; Szokoloczi O; Kéri GY Anticancer Res; 2008; 28(5A):2769-74. PubMed ID: 19035308 [TBL] [Abstract][Full Text] [Related]
36. Antitumor effects of miconazole on human colon carcinoma xenografts in nude mice through induction of apoptosis and G0/G1 cell cycle arrest. Wu CH; Jeng JH; Wang YJ; Tseng CJ; Liang YC; Chen CH; Lee HM; Lin JK; Lin CH; Lin SY; Li CP; Ho YS Toxicol Appl Pharmacol; 2002 Apr; 180(1):22-35. PubMed ID: 11922774 [TBL] [Abstract][Full Text] [Related]
37. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor. Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells. Martin KJ; Chen SF; Clark GM; Degen D; Wajima M; Von Hoff DD; Kaddurah-Daouk R J Natl Cancer Inst; 1994 Apr; 86(8):608-13. PubMed ID: 8145276 [TBL] [Abstract][Full Text] [Related]